Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Belinda Neil

Belinda Neil

Aland Islands

Begum ENGUR

Begum ENGUR

UAE

Asa Westrin

Asa Westrin

USA

Bethany Devenish

Bethany Devenish

Australia

Candice Conner

Candice Conner

Canada

Catherine MacWillie

Catherine MacWillie

USA

Darviri Christina

Darviri Christina

France

David Muss

David Muss

Italy

Oncology Research 2020

About Conference


Conferenceseries Ltd welcomes everyone all over the world to participate in the “Global Summit on Oncology and Hematology” during September 24-25, 2020 Berlin, Germany.

Oncology 2020 coordinates towards tending to main issues as well as future strategies of Cancer. This will be the biggest and most encouraging universal gathering where the program incorporates Clinical Oncologists, Registered Nurses, Nurse specialists and the whole restorative group required in patient care, scientists, proficient, early profession people who wish to learn standards of tumour immunology and immunotherapy well as leaders will come to examine on different parts of challenges, risks and investment opportunities of Cancers. Global Cancer at Singapore will manage Cancer Prevention, Diagnosis, and Treatment of illnesses of the Organ-related Cancers and its inventive strategies. Global Cancer  will also provide the three days of discussions on techniques and systems identified with administration and quality change of Cancer and in addition to investigate the new thoughts and ideas on worldwide scale and the themes incorporate lung malignancy, bosom disease, bone tumour, leukaemia, blood cancer, cervical tumour, colon-rectum disease, pediatric malignancy, surgical tumour, Prostate growth, thyroid malignancy.

ConferenceSeries llc LTD which contains 3000+ Global Events with more than 600+ Conferences, 1200+ Symposiums and 1200+Workshops on assorted Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is arranging meetings everywhere throughout the globe. Conferenceseries LLC has various Cancer Gatherings, Cancer meeting, worldwide growth gathering, European Oncology Conferences, Surgical oncology like skin tumour gathering, bosom malignancy meeting, liver malignancy gathering, Lung Cancer gatherings, and Oncology Conferences where learning exchange happens through civil arguments, round table discourses, notice introductions, workshops, symposia and presentations and which gets potential outcomes for treating the maladies with new time, innovation and research.


 

Sessions/Tracks

Track 1. Hematology and Pharma Industry

The worldwide market of thehematological medications in top point as it is frequently anticipated to be enhanced over the couple of decades. As per the worldwide market expert the haematology medicate and demonstrative market is relied upon to develop at the rate of 7.5% from 2015-2020.

Biological Drugs and oncology, Bristol-Mayers Squibb, Bristol-Myers Squibb, Boehringer Ingelheim, Roche, Novartis, Celgene, Johnson and Johnson, Lilly, Takeda, 

Track 2.Cancer Prevention

Cancer Prevention is an achievement hauls towards lower possibility of getting disease. Cancer prevention is the practice of taking active measures to decrease the incidence of cancer and mortality. The practice of prevention is dependent upon both individual efforts to improve lifestyle and seek preventative screening and socioeconomic or public policy related to cancer prevention. Greater than a reported 75% of cancer deaths could be prevented by avoiding risk factors including: tobaccooverweight obesity, an insufficient diet, physical inactivityalcoholsexually transmitted infections, and air pollution.   Malignancy can be taken care of by numerous medications like chemotherapy, radiation treatment, hormonal treatment, target treatment, and palliative consideration.

 

  • Psychological Aspects
  • Hereditary Aspects
  • Food Habitats
  • Immunized Aspects
  • Chronic Inflammation

Track 3. Hormonal Therapy

 

Hormonal therapy is the use of hormones in medical treatment. Treatment with hormone antagonists may also be referred to as hormonal therapy or antihormone therapy. Androgen replacement Therapy (ART), and transgender hormone therapy. In women, the body of the women is comprised of ovaries. Estrogen creates hormone receptor that prompts the positive bosom malignancy development. Subsequently, gathering the measure of estrogen can abbreviate the danger of an early life-arrange. In few cases, the medical procedure will goes about as a noteworthy job, for example, the ovaries just as the fallopian tubes reallocated by the careful technique so as to treat the hormone-receptor-positive bosom malignant growth. It is important to realize that hormonal treatment isn't hormone substitution treatment (HRT).

  • LHRH Agonists
  • Oophorectomy
  • Aromatase Inhibitors
  • Side Effects of Hormonal Therapy
  • Role of Anti Androgens

Track 4. Key Role of Pathology in Cancer

Pathologists are among the most important members of a patient’s cancer care team. They work to diagnose and determine the stage of cancer, setting the course for what comes next in the treatment journey.. Pathologists are at the heart of cancer prevention through screening, diagnosis, monitoring and treatment. Pathology is the service that handles the blood samples and the cells and tissues removed from suspicious ‘lumps and bumps’. Cancer pathology’s key role in diagnosing and treating a complex disease, it’s important to stay up lumps and bumps to date on new technologies and breakthroughs that continue to shape the ever-evolving landscape of cancer care.

  • Anatomical Pathology
  • Oncopathology
  • Molecular pathology of cancer
  • Pathology in cancer diagnostics
  • Cancer Cytopathology
  • Pediatric pathology

Track 5. Cancer & Stem Cell Therapy

Cancer stem cells (CSCs) are cancer cells that possess characteristics associated with normal stem cells, specifically the ability to give rise to all cell types found in a particular cancer sample. CSCs are therefore tumorigenic (tumor-forming), perhaps in contrast to other non-tumorigenic cancer cells. CSCs may generate tumors through the stem cell processes of self-renewal and differentiation into multiple cell types. Existing cancer treatments have mostly been developed based on animal models, where therapies able to promote tumor shrinkage were deemed effective.

  • Cancer Stem Cells
  • Stem Cell Transplantation
  • Bone Marrow Transplantation
  • CSCs and Cancer Treatment

Track 6. Cancer Nanotechnology

Recognizing cancer as a group of diseases caused by nanostructural problems (i.e. with DNA) and also that there are unique benefits to approaches inherently involving nanoscale structures and processes to treat the disease, the journal Cancer Nanotechnology aims to disseminate cutting edge research; to promote emerging trends in the use of nanostructures and the induction of nanoscale processes for the prevention, diagnosis, treatment of cancer; and to cover related ancillary areas. Cancer nanotechnology is a branch of nanotechnology concerned with the application of both nanomaterials and nanotechnology approaches to the diagnosis and treatment of cancer.

  • Cancer Microenvironment
  • Chemo Drugs
  • Stealth Nanoparticles and Tumor Penetrating Peptides
  • New Nanomaterials
  • Early Diagnosis and Imaging
  • Advances in Nanotechnology

 

Track 7. Cancer Chemotherapy

Cancer cells keep growing without control. Chemotherapy is drug therapy for cancer. It works by killing the cancer cells, stopping them from spreading, or slowing their growth. However, it can also harm healthy cells, which causes side effects. Cancer can be treated by surgerychemotherapyradiation therapyhormonal therapytargeted therapy and synthetic lethality. Cancer genome sequencing helps in determining which cancer the patient exactly has for determining the best therapy for the cancer. A number of experimental cancer treatments are also under development. Under current estimates, two in five people will have cancer at some point in their lifetime

  • Treatment strategies
  • Adverse effects
  • Limitations
  • Cancer Therapeutics, Novel and experimental approaches

 

Track 8.Neonatal and Pediatric Oncology

Neonatal & Pediatric Oncology is the term used to comprise all malignant conditions among neonates & children with cancer. The most common childhood cancers are, NeuroblastomaRetinoblastomaWilms tumor and brain tumors, such as gliomas. Childhood cancers are very rare and may differ from adult cancers in the way they grow, spread, treated, and respond to treatment.

  • Pediatric Oncology Nursing
  • Integrative Pediatric Oncology
  • Palliative Care in Pediatric Oncology
  • Pioneers in pediatric oncology
  • Supportive Care in Pediatric Oncology
  • Fetal and Neonatal Pathology
  • Radiological Imaging of the Neonate

Track 9.Ovarian Cancer

 

Ovarian Cancer is a type of cancer which occurs in one or two of the ovaries. This type of cancer often goes undetected until it is spread to pelvis and uterus at this stage it is much difficult to treat the cancer. Risk factors often include age, family history of cancer, inherited gene mutations, estrogen replacement therapy, age when mensuration started and ended. Ovarian cancer often goes undetected until it has spread within the pelvis and stomach. At this late stage, ovarian cancer is more difficult to treat and can be fatal. Ovarian cancer often has no symptoms in the early stages. Later stages are associated with symptoms, but they can be non-specific, such as loss of appetite and weight loss. Surgery and chemotherapy are generally used to treat ovarian cancer.

  • Epithelial tumors
  • Stromal tumors
  • Germ cell tumors

Track 10. Oral Oncology

Oral disease is otherwise called mouth tumor. The oral growth may happen at any place in the mouth, on the surface of the tongue, on the lips, inside the cheek, in the gums, in the sense of taste of the mouth, in the salivary organs. Manifestations of oral disease incorporates; fixes on the coating of the mouth or tongue, mouth ulcers or wounds that don't recuperate, free teeth with obvious reason, jaw torment, excruciating tongue, change in voice, ear torment, sore throat and so forth and medicines for Oral growth are surgery, radiation treatment, chemotherapy.

  • Radiation Therapy
  • Chemotherapy
  • Pretreatment Dental Evaluation
  • Surgical Pathology of Oral Cancer
  • Oral and Maxillofacial Reconstruction

Track 11.Gynecology, Infectious Diseases and Oncology

Contaminations in the female genitalia and the extra sex organs are regularly known as Gynecologic Infectious Diseases. A portion of the irresistible infections is Vulvovaginitis, Cervicitis, Pelvic Inflammatory Diseases, and Sexually Transmitted Diseases. Gynecologic Oncology is a specific field that arrangements with growths relating to the female genitalia and conceptive framework. Ovarian malignancy, uterine disease, vaginal growth, cervical tumor, and vulvar disease are each of the pieces of gynecologic oncology.

  • Through direct contact with a person who is sick.
  • • Through indirect contact, when you touch something that has germs on it.
  • Through insect or animal bites
  • Through contaminated food, water, soil, or plants

Track 12 .Hormone receptor positive breast tumor

A hormone-receptor-positive (HR+) tumor is a tumor which consists of cells that express receptors for certain hormones. The term most commonly refers to estrogen receptor positive estrogen receptor positive tumors  (i.e. tumors that contain estrogen receptor positive cells), but can also include progesterone receptor positive tumors. Estrogen-receptor-positive tumors depend on the presence of estrogen for ongoing proliferation.

  • Lowering systemic levels of estrogen.
  • Achieved by the use of drugs from the aromatase inhibitor category.
  • Blockage of the estrogen receptors on the cancerous cells
  • Treating hematological malignancies such as lymphoma and leukemia (cancers)
  • The science of blood transfusion and the work of a blood bank

Track 13. Hematological Oncology

The finding of treatment and counteractive action of blood illnesses (hematology) and malignancy (oncology) and investigation in them. Hematology-oncology incorporates such sicknesses as iron lack paleness, hemophiliasickle cell illness, the thalassemias, leukemias and lymphomas, and in addition tumors of different organs.

  • Treating bleeding disorders such as hemophilia and idiopathic Thrombocytopenic purpura
  • Treating Hemoglobinopathies
  • Bone marrow and stem cell transplantation
  • Processing and testing
  • Compatibility testing
  • Infection

Track 14 .Blood Transfusion

Blood transfusion is a process in which donated blood/blood products are transferred into one’s circulation intravenously. This is a potentially lifesaving procedure used for various medical conditions to replace the lost components of blood due to surgery or injury. However, minor to severe problems do occur occasionally. Most common complications include allergic reactions, blood-borne infections, fever, acute immune hemolytic reaction.

  • Blood donation
  • Immunologic reaction
  • Compatibility testing
  • Infection

Track 15. Blood Transplantation, Thrombosis and Hemostasis

The umbilical cord is a conduit between the developing embryo or fetus and the placenta. The umbilical vein supplies the fetus with  nutrient-rich blood from the placenta The hematopoietic bone marrow transplant, the HSC are removed from a large bone of the donor, typically the pelvis, through a large need let that reaches the center of the bone. Acute myeloid leukemia is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal white blood cells that accumulate in the bone marrow and interfere with the production of normal blood cells and the Thrombosis is the formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system. The Hemostatic is a process which causes bleeding to stop, meaning to keep blood within a damaged blood vessel this is the first stage of wound healing.

  • Venous thrombosis
  • Platelet activation
  • Normal blood cells

 

Track 16.Hematology & Oncology Nursing

Oncology Nursing is a field including practice incorporates the jobs of direct guardian, instructor, specialist Hematology & Oncology Nursing:, head, and scientist. Oncology nursing care can defined as meeting the various needs of oncology patients during the time of their disease including appropriate screenings and other preventative practices, symptom management, care to retain as much normal functioning as possible, and supportive measures upon end of life. Often abbreviated to Heme/Onc Nurses are those individuals who work with patient populations undergoing both solid and bloodborne cancer diagnoses, treatment and remission.Management & Palliative Care

  • Assessing Physical & Emotional Status
  • Treatment Plans
  • Symptom Management
  • Supportive Care
  • Direct Patient Care

Track 17. Hematology & Oncology Nursing

Oncology Nursing is a field including practice incorporates the jobs of direct guardian, instructor, specialist Hematology & Oncology Nursing:, head, and scientist. Oncology nursing care can defined as meeting the various needs of oncology patients during the time of their disease including appropriate screenings and other preventative practices, symptom management, care to retain as much normal functioning as possible, and supportive measures upon end of life. Often abbreviated to Heme/Onc Nurses are those individuals who work with patient populations undergoing both solid and bloodborne cancer diagnoses, treatment and remission.Management & Palliative Care

  • Assessing Physical & Emotional Status
  • Treatment Plans
  • Symptom Management
  • Supportive Care
  • Direct Patient Care

Track 18. Cancer: Lifestyle and Nutrition

Many factors impact the development of cancer. Over the last 25 years, science has displayed that diet, body weight and physical activity  especially being overweight or obese are leading risk factors for obtaining certain types of cancer. The main behavioral and environmental risk factors for cancer death in the world are related to diet and physical inactivity, use of addictive substances, sexual and reproductive health and exposure to air pollution and use of contaminated needles. The body’s ability to confront cancer may be helped by succeeding a healthy diet, staying physically active, and escaping excess body fat. Cancer and cancer treatments can also alter your body's ability to tolerate certain foods and use nutrients.

  • Lifestyle Factors
  • Combined Impact
  • Population Attributable Risks
  • Investigation into Cancer and Nutrition (EPIC)

Tracks 19 .Cancer Immunology & Immunotherapy

 

Cancer immunology is a stream of immunology that studies communications between the immune system and cancer cells (also called tumors or malignancies). It is a field of research that intent to discover cancer immunotherapies to treat and decelerate evolution of the disease. The human immune system mounts natural endogenous response to foreign cells. The gamut of genetics and epigenetics changes occurring in tumors provides diverse set of antigenic repertoire that host’s immune system can exploit to distinguish tumour versus their normal healthy counterparts. The immune response, including the detection of cancer-specific antigens, forms the basis of targeted therapy (such as vaccines and antibody therapies) and tumor marker-based diagnostic tests.

  • Host-Tumor Relation
  • Clinical Cancer immunology
  • Cancer Antigens & Vaccines
  • Cellular Immunotherapy
  • Antibody Therapy
  • Antibody Therapy
  • Cytokine Therapy
  • Combination & Combinatorial Ablation and Immunotherapies

Track 20.Biomarkers in Hematology and Oncology

A cancer biomarker indicates to a substance or process that symbolizes the presence of cancer in the body. A biomarker might be a molecule secreted by a tumor or a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be preferred for cancer diagnosis, prognosis, and epidemiology. A cancer biomarker refers to a substance that indicates the presence of cancer in the body. A biomarker may be a molecule produced by a tumor or a specific response of the body to the presence of cancer. Epigenetic, proteomic, genetic, glycomic and imaging biomarkers can be used for cancer diagnosis, prognosis and epidemiology.

 A cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body to the presence of cancer, The most vital use of biomarkers today is to diagnose which therapies a patient’s cancer may or may not respond to

  • Molecular Cancer Biomarkers
  • Predictive & Prognostic Biomarkers
  • Predictive & Prognostic Biomarkers
  • Companion Biomarker
  • Patient Assessment & Education
  • Forensic Pathology

 

Target Audience

.         Oncologists

·         Radiologists

·         Pathologists

·         Students

·         Oncology Associations & Societies

·         Business Entrepreneurs

·         Hematologists

·         Academicians

·         Research Scholars

·         Software Developing Companies

·         Medical Devices Companies

·         Biomedical Companies

·         Biotechnology Companies

·         Data Management Companies

 

Why to attend?

With people from around the world focused on getting some answers concerning Oncology and Cancer; this is your most obvious opportunity to accomplish the greatest cluster of individuals from the Cancer people group, Oncology Society, European Oncology Conferences. Coordinate presentations, disperse information, meet with present and potential specialists, make a sprinkle with new pharmaceutical progressions, and get name affirmation at this three day event. Broadly acclaimed speakers, the most recent systems, changes, and the most a la mode invigorates in Oncology are indications of this meeting.

Market Analysis

Cancer is the name given to a collection of related diseases. In all types of cancer, some of the body’s cells begin to divide without stopping and spread into surrounding tissues. Cancer can start almost anywhere in the human body, which is made up of trillions of cells. Normally, human cells grow and divide to form new cells as the body needs them. When cells grow old or become damaged, they die, and new cells take their place. When cancer develops, however, this orderly process breaks down. As cells become more and more abnormal, old or damaged cells survive when they should die, and new cells form when they are not needed. These extra cells can divide without stopping and may form growths called tumors. The global cancer diagnostics market is expected to grow at a CAGR of 11.8% during the forecast period 2017-2023. There are several methods of diagnosing cancer today such as biopsy based, endoscopy based, imaging procedure, tumor cancer diagnostics and many more. Population affected with cancer is showing a tremendous growth during last few years, which create the requirement of advanced technology for diagnosis cancer on early stage. According to the American Cancer Society, in 2017, it is estimate that around 161,360 new cases of prostate cancer will be diagnosed and around 26,730 deaths occur owing to prostate cancer in the United States. Thus, many companies are involved in collaboration in order to provide better technology for diagnosis the cancer. In this regards, in January, 2015, Roche and Qualcomm Incorporated entered into a strategic collaboration to improve remote monitoring and management of patients with chronic disease.

Cancer associations in the world

  • American cancer society
  • American childhood cancer organization
  • Acoustic neuroma association of Australia
  • American gastroenterologist association
  • Association of international cancer research
  • Association for the study of lung cancer
  • Association of community cancer centers
  • Association of population-based cancer registers in Germany
  • Australian Association of smoking cessation professionals
  • Australian prostate cancer research
  • Avon breast cancer crusade
  • Bangladesh cancer society
  • Breast screen Australia program
  • Bulgarian cancer association
  • Canadian Association of pharmacy in oncology
  • Canadian cancer society
  • Cancer Association of South Africa
  • Cancer Council Australia
  • Cancer research institute
  • Cancer Research UK
  • Cancer society Brazil
  • Children’s cancer association
  • Children’s cancer and leukemia group
  • Dutch cancer society
  • Dutch cancer registry
  • Egypt cancer society
  • European organization for research and treatment of cancer
  • Foundation for women’s cancer
  • French cancer society
  • German cancer society
  • German society of radiation oncology
  • Health Canada
  • Hong Kong Neuro-oncology society
  • Indian cancer society
  • International agency of research and cancer
  • International lung cancer consortium
  • Japan lung cancer society
  • Kidney cancer association
  • Korean cancer association
  • Leukemia & lymphoma society
  • Lung cancer Canada
  • Ministry of health – Armenia
  • National brain tumor society
  • National cancer institute
  • National lung cancer partnership
  • Oral cancer foundation
  • Ovarian Cancer Australia
  • Pancreatic cancer action network
  • Prostate cancer Canada
  • Saudi oncology society
  • Singapore cancer society

Pharmacy companies dealing with cancer drugs

  • Roche
  • Novartis
  • Celgene
  • Johnson & Johnson
  • Bristol-Myers Squibb
  • Lilly
  • Takeda
  • AstraZeneca
  • Merck & Co
  • Amgen
  • Pfizer
  • Astellas
  • Bayer
  • Otsuka
  • Sanofi

To Collaborate Scientific Professionals around the World

Conference Date September 24-25, 2020

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

Journal of Oncology Research and Treatment Advances in Cancer Prevention Journal of Clinical & Experimental Oncology Archives in Cancer Research

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

Keytopics

  • Angiogenesis Inhibitors
  • Anti-Cancer Agents In Medicinal Chemistry
  • Big Data Analytics
  • Blood Cancer
  • Breast Cancer
  • Can Cannabis Cure Cancer
  • Cancer & Stem Cell Therapy
  • Cancer : Alternative Medicine
  • Cancer Alternative Medicine
  • Cancer Awareness And Survival
  • Cancer Biopsy
  • Cancer Case Reports
  • Cancer Cell Biology
  • Cancer Chemotherapy
  • Cancer Clinical Trails
  • Cancer Diagnostics Tools, Technologies And Procedures
  • Cancer Drug Development
  • Cancer Drugs
  • Cancer Epidemiology
  • Cancer Epigenomics
  • Cancer Genetics And Genomics
  • Cancer Herbal Supportive Therapy
  • Cancer Immunology & Immunotherapy
  • Cancer Inflamation And Immune Tolerance
  • Cancer Management & Prevention
  • Cancer Metabolomics
  • Cancer Metastasis
  • Cancer Nanotechnology
  • Cancer Pathophysiology
  • Cancer Pharmacology
  • Cancer Prevention & Research
  • Cancer Radiology
  • Cancer Science
  • Cancer Stem Cell Therapy
  • Cancer Therapeutic Resistance
  • Cancer Therapeutics And Novel Approaches
  • Cancer Vaccines
  • Cancer-Case Study
  • Cancer: Mode Of Existence
  • Cancer: Psychological & Social Aspects
  • Case Reports
  • Cervical Cancer
  • Clinical Cancer Research
  • Clinical Oncology
  • Collateral Lethality In Cancer
  • Complementary & Alternative Methods And Cancer
  • Computational Oncology
  • Drug Development
  • Etiology Of Cancer
  • Exosome Research
  • Gastric Cancer And Japan
  • Genetic Cancer Susceptibility
  • Growth Of Cancer Drug Market
  • Head And Neck Surgery
  • Health Improvement Program
  • Hemato Oncology
  • Hospice In Cancer
  • Image Guided Radiation Therapy
  • Immunotherapy
  • Infections And Cancer Epidemiology
  • Intensity Modulated Radiation Therapy
  • Lung Cancer
  • Main Causes Of Cancer
  • Management Of Cancer
  • Mechanisms Of Carcinogenesis
  • Medical Imaging
  • Medical Oncology
  • Molecular Diagnostics
  • Molecular Medicine And Diagnostics
  • Molecular Targeted Cancer Therapy And Precision Medicines
  • Most Prevalent Cancers
  • Musculo Skeletal Oncology
  • Nanoparticles In Cancer Therapy
  • Nanotechnology
  • Nanotechnology In Cancer
  • Nanotechnology In Cancer Treatment
  • Natural Methods For Treatment Of Cancer
  • Neuro Onco Surgery
  • Novel Approaches To Cancer Therapeutics
  • Nuclear Medicine
  • Oncogenomics
  • Oncology Diagnosis:tools, Technology And Procedures
  • Oncology Nursing
  • Oncology: Sub-Specialities
  • Operomics
  • Organ-Defined Cancers
  • Organ-Specific Cancer
  • Palliative Therapy
  • Pediatric Hemato Oncology
  • Phototherapy
  • Precision Cancer Medicine & Oncology
  • Precision Medicine
  • Prostate Cancer
  • Proton Beam Therapy
  • Radiation Oncology
  • Radiotherapy
  • Recent Advances In Radiation Therapy
  • Recent Diagnostic Techniques
  • Regenerative Medicine
  • Robotic Oncology
  • Signs And Symptoms Of Different Cancers
  • Solid Tumour Oncogenesis
  • Stages Of Cancers
  • Stem Cell Transplant
  • Suicide Gene Therapy
  • Surgery
  • Surgical Oncology
  • Synthetic Lethality In Cancer
  • Tumor Supressor Gene(TSG)
  • Tumor Virology
  • Tumour Immunology & Immunotherapy
  • Uterine Cancer